54 results
DEFM14A
CERE
Cerevel Therapeutics Holdings Inc
18 Jan 24
Proxy related to merger
7:44am
, disability, real property, personal property, sales, use, transfer, registration, ad valorem, value added, alternative or add-on minimum or estimated
PRER14A
dy9gfsm2odbp944s5su
18 Jan 24
Preliminary revised proxy
7:19am
PREM14A
5o16jgssy0wvm13m9
5 Jan 24
Preliminary proxy related to merger
5:13pm
DEFA14A
lqbmet85
7 Dec 23
Additional proxy soliciting materials
8:02am
8-K
EX-2.1
r99gbbne2y0m8zky
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
EX-3.1
0qnpz3oklafu
15 Jun 22
Cerevel Therapeutics Announces Updates to its Board of Directors
6:30am
424B4
9n8krgoh5elg2hhcy1
2 Jul 21
Prospectus supplement with pricing info
5:22pm
424B3
ak7sabfmc647hgp
29 Jun 21
Prospectus supplement
6:57am